Related Experiment Videos
Recent developments in microvascular angina
1Department of Medicine, Section of Cardiology, Tulane University Medical Center, 1415 Tulane Avenue, HC-19, New Orleans, LA 70112, USA.
Current Atherosclerosis Reports
|March 20, 2001
Summary
Microvascular angina, also known as Syndrome X, is a complex heart condition resulting from various factors. Understanding its causes and improving treatment for this heterogeneous entity remains a challenge.
Area of Science:
- Cardiology
- Vascular Biology
- Genetics
Background:
- Microvascular angina (Syndrome X) presents as a heterogeneous clinical entity.
- It arises from a complex interplay of genetic, coronary microvascular, metabolic, and clinical factors.
- The intricate interactions among these contributing abnormalities are not well understood.
Purpose of the Study:
- To elucidate the multifaceted nature of microvascular angina.
- To highlight the diagnostic considerations in patients presenting with anginal symptoms and absent epicardial coronary artery disease.
- To review the current therapeutic strategies for managing this condition.
Main Methods:
- Review of existing literature on microvascular angina.
- Analysis of etiological factors including genetic, vascular, and metabolic components.
- Examination of clinical manifestations and diagnostic criteria.
Main Results:
- Microvascular angina is characterized by diverse cardiac manifestations and complications.
- Diagnosis is indicated for patients with angina and no significant epicardial coronary artery narrowing.
- Treatment approaches are often challenging and evolving.
Conclusions:
- Microvascular angina is a complex syndrome with poorly understood interactions between causative factors.
- Effective management requires a comprehensive understanding of its heterogeneous origins.
- Current therapeutic guidelines include beta-blockers, ACE inhibitors, and calcium channel blockers.